Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RemeGen Co., Ltd. Board/Management Information 2021

Jun 1, 2021

51206_rns_2021-06-01_f671fc18-cd7d-4e7c-956f-0991f6dbee1c.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

==> picture [112 x 39] intentionally omitted <==

RemeGen Co., Ltd.[*]

榮 昌 生 物 製 藥( 煙 台 )股 份 有 限 公 司 (the ‘‘Company’’)

(A joint stock company incorporated in the People’s Republic of China with limited liability)

(Stock Code: 9995)

LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS

The members of the board of directors (the ‘‘Board’’) of the Company are set out below:

Executive Directors

  • Mr. Wang Weidong (Chairman of the Board)

  • Dr. Fang Jianmin

  • Dr. He Ruyi

  • Mr. Lin Jian

Non-executive Directors

  • Dr. Wang Liqiang

  • Dr. Su Xiaodi

Independent non-executive Directors

  • Ms. Yu Shanshan

  • Mr. Hao Xianjing

  • Dr. Ma Lan

– 1 –

There are four Board committees. The composition of the Board committees is set out in the table below:

the table below: the table below:
Committee
Director
Strategy
Committee
Committee
Director
Audit
Committee
Remuneration
and Appraisal
Committee
Nomination
Committee
Strategy
Committee
Mr. Wang Weidong C M
Dr. Fang Jianmin C
Dr. He Ruyi M
Mr. Lin Jian M
Dr. Wang Liqiang M M
Dr. Su Xiaodi M
Ms. Yu Shanshan M C M
Mr. Hao Xianjing C M M
Dr. Ma Lan Dr. Ma Lan

Notes:

  • C Chairperson of the relevant Board committees M Member of the relevant Board committees

Yantai, The People’s Republic of China June 1, 2021

  • For identification purpose only

– 2 –